Nanowell-mediated two-dimensional liquid chromatography enables deep proteome profiling of <1000 mammalian cells. Issue 34 (25th July 2018)

• Record Type: Journal Article
• Authors: Dou, Maowei; Zhu, Ying; Liyu, Andrey; Liang, Yiran; Chen, Jing; Piehowski, Paul D.; Xu, Kerui; Zhao, Rui; Moore, Ronald J.; Atkinson, Mark A.; Mathews, Clayton E.; Qian, Wei-Jun; Kelly, Ryan T.
• Is Part Of: Chemical science. Volume 9:Issue 34(2018)
• Page Start: 6944
• Page End: 6951
• Publication Date: 2018-07-25
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c8sc02680g
• Languages: English
• ISSNs: 2041-6520

Abstract

Abstract : Miniaturized multidimensional peptide separations can greatly increase the coverage in proteome profiling for trace samples. Abstract : Multidimensional peptide separations can greatly increase the depth of coverage in proteome profiling. However, a major challenge for multidimensional separations is the requirement of large biological samples, often containing milligram amounts of protein. We have developed nanowell-mediated two-dimensional (2D) reversed-phase nanoflow liquid chromatography (LC) separations for in-depth proteome profiling of low-nanogram samples. Peptides are first separated using high-pH LC and the effluent is concatenated into 4 or 12 nanowells. The contents of each nanowell are reconstituted in LC buffer and collected for subsequent separation and analysis by low-pH nanoLC-MS/MS. The nanowell platform minimizes peptide losses to surfaces in offline 2D LC fractionation, enabling >5800 proteins to be confidently identified from just 50 ng of HeLa digest. Furthermore, in combination with a recently developed nanowell-based sample preparation workflow, we demonstrated deep proteome profiling of >6000 protein groups from small populations of cells, including ∼650 HeLa cells and 10 single human pancreatic islet thin sections (∼1000 cells) from a pre-symptomatic type 1 diabetic donor.